Repligen Corporation (RGEN)
RGEN price $180.36 +1.48 +0.83%
- Ticker
- RGEN
- Price
- $180.36
- Change
- +1.48 +0.83%
- Market cap
- $11.45B
- P/E
- 243.64
- Forward P/E
- 87.50
- Sector
- Healthcare
- Industry
- Medical - Instruments & Supplies
- Stocklytics score
- 44
Repligen Corporation specializes in the creation and distribution of advanced bioprocessing technologies and integrated systems. These solutions are vital for various stages of biological drug production, serving clients across North America, Europe, the Asia Pacific region, and other international markets. The company's diverse product portfolio includes crucial components for biomanufacturing. This encompasses…